Join to view full profile
2080 Century Park East#1206Los Angeles, CA 90067
Phone+1 310-282-0525
Fax+1 310-201-0662
Dr. Karyotakis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1996 - 1999
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1993 - 1996- University of Texas Health Science Center at HoustonPost-Doctoral Fellowship, Infectious Disease, 1991 - 1993
University of Crete School of Health SciencesClass of 1991
Certifications & Licensure
CA State Medical License 1996 - 2026
Clinical Trials
Publications & Presentations
PubMed
- 8 citationsEfficacy of continuous flucytosine infusion against Candida lusitaniae in experimental hematogenous murine candidiasis.N. C. Karyotakis, Elias Anaissie
Antimicrobial Agents and Chemotherapy. 1996-12-01 - 6 citationsSCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.N C Karyotakis, M C Dignani, Elias Anaissie
Antimicrobial Agents and Chemotherapy. 1995-03-01 - 14 citationsActivities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.N. C. Karyotakis, M. C. Dignani, Ray Y Hachem, Elias Anaissie
Antimicrobial Agents and Chemotherapy. 1995-02-01
Research History
- P.I.IBD vedolizumab IBD ETRO2007 - 2019
Other Languages
- Spanish, Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
